Notice: Undefined index: PATH_INFO in /home/u842710795/domains/sciencworldpublishing.org/public_html/abstract.php on line 3
Tumor Cell Antigenicity as Performance Hierarchy of Equilibrating Interactivity of Systems of Receptivity and Activation of Lymphocyte Subsets 1

Current Trends In Medical And Clinical Case Reports (ISSN:2769-7088)

Tumor Cell Antigenicity as Performance Hierarchy of Equilibrating Interactivity of Systems of Receptivity and Activation of Lymphocyte Subsets

Lawrence M. Agius

Department Of Pathology, University Of Malta Medical School, Mater Dei Hospital, Tal-Qroqq, Msida, 27 “Ballarat”, Guzeppe Caruana Street, Tal-Virtu, Rabat, Rbt09, Malta, Europe

*Corresponding author: Lawrence M. Agius, Department Of Pathology, University Of Malta Medical School, Mater Dei Hospital, Tal-Qroqq, Msida, 27 “Ballarat”, Guzeppe Caruana Street, Tal-Virtu, Rabat, Rbt09, Malta, Europe, Email: lawrence.agius@um.edu.mt

Citation: Lawrence M. Agius (2020) Tumor Cell Antigenicity as Performance Hierarchy of Equilibrating Interactivity of Systems of Receptivity and Activation of Lymphocyte Subsets. Current Trends Med Clin Case Rep, 1(1); 1-3

 

Copyright: © 2020, Lawrence MA, This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited


ABSTRACT

A multifold dimensionality within equilibrating performance of the immune response belies the development of hierarchical dimensions as conveyed by development of evolutionary dynamics of such immune response.  The realization of significance in activation of both helper and cytotoxic T lymphocytes reflects the complexity of immunogenicity as a web-wide dimension in the further projection of injury to systems of tumor proliferation and infiltration of brain tissue.  It is perhaps within systems of enhanced participation of tumor cell release of antigens that there exists the equilibration performance for further modification of the immune response towards tumor dynamics and cell constitutive series of antigen identities.

Indexing Partners

image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing
image-missing